Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>Products>This Product

HiFect® Transfection Reagent

Product Description
HiFect® Transfection Reagent is Lonza´s stand alone biochemical transfection reagent for standard cell lines. While the well-established Nucleofector® Technology remains the best system for gene transfer into notoriously difficult-to-transfect cell lines and primary cells, HiFect® Transfection Reagent is the cost-effective alternative for standard cell lines. As a company with great expertise in transfection technology, Lonza prides itself on having the ideal solution for any transfection challenge.

HiFect® Benefits

    Superior transfection efficiency and cell viability
    Cost effective
    Suitable for DNA and siRNA transfections
    Suitable for high throughput applications
    Scientific Support by our trusted and experienced team
Product HiFect® Transfection Reagent
Company Lonza - Products
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified

Scientific News
Urine Excretion From Stem Cell-Derived Kidneys
Researchers report a strategy for enabling urine excretion from kidneys grown from stem cells.
Stem Cell Research Hints at Evolution of Human Brain
Researchers at UC San Francisco have succeeded in mapping the genetic signature of a unique group of stem cells in the human brain that seem to generate most of the neurons in our massive cerebral cortex.
The Final Word on STAP
Researchers fail to replicate STAP study; computational analysis reveals genomic inconsistency.
CRI Scientists See Through Bones
Findings uncover new details about blood-forming stem cells.
Scientists Sequence Genome Of Worm That Can Regrow Body Parts
Worm’s genome could lead to better understanding of its regenerative prowess and advance stem cell biology.
Stem Cell-Derived 'Organoids' Help Predict Neural Toxicity
A new system developed by scientists may provide a faster, cheaper and more biologically relevant way to screen drugs and chemicals that could harm the developing brain.
New Way To Repair Nerves
Tufts University biomedical engineers recently published the first report of a promising new way to induce human mesenchymal stem cells to differentiate into neuron-like cells:treating them with exosomes.
Pancreatic Cancer Stem Cells Could be "Suffocated" by Anti-diabetic Drug
A new study shows that pancreatic cancer stem cells (PancSCs) are virtually addicted to oxygen-based metabolism, and could be “suffocated” with a drug already used to treat diabetes.
Filling A Void In Stem Cell Therapy
A new porous hydrogel could boost the success of stem-cell-based tissue regeneration.
Diabetes Research Institute's First Patient In Biohub Trial No Longer Requires Insulin Therapy
New transplant technique restores natural insulin production in type 1 diabetes.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos